Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Trial    crawled date : 2021 - 05 - 04    save search

STAG Industrial Announces First Quarter 2021 Results
Published: 2021-05-04 (Crawled : 20:00) - stagindustrial.com
STAG | $34.93 1.6% 0.0% 1.5M twitter stocktwits trandingview |
Finance
| | O: -0.41% H: 0.32% C: -2.97%

results trial
STAG Industrial Announces Promotion Of William R. Crooker To President
Published: 2021-05-04 (Crawled : 20:00) - stagindustrial.com
STAG | $34.93 1.6% 0.0% 1.5M twitter stocktwits trandingview |
Finance
| | O: -0.41% H: 0.32% C: -2.97%

trial
Pharmaceutical and Life Sciences Real World Evidence Market Outlook 2021-2030: Comparison of Randomized Clinical Trials and Real World Evidence
Published: 2021-05-04 (Crawled : 18:00) - prnewswire.com
BSX | $67.33 -0.13% 0.0% 6.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 0.0% C: -0.39%

clinical trials ce mark life science trial
USA TODAY Journalists Publish Documentary and Long-Form Column After Being Embedded in the Minneapolis Community for the Chauvin Trial
Published: 2021-05-04 (Crawled : 14:00) - gannett.com
GCI 4 | $2.6 4.0% 0.0% 1.4M twitter stocktwits trandingview |
Consumer Services
| | O: -0.87% H: 0.22% C: -0.22%

oda trial
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
Published: 2021-05-04 (Crawled : 14:00) - biospace.com/
GNPX | $2.2194 -2.31% 38K twitter stocktwits trandingview |
Health Technology
| | O: -2.9% H: 13.04% C: 0.0%

treatment lung cancer cancer trial
Global Industrial Coatings Market Outlook Report 2021-2026: Use Of Innovative Coatings In Automotive and Electronics Industry and Increasing Demand For Protective & Environment-Friendly Coatings
Published: 2021-05-04 (Crawled : 13:00) - prnewswire.com
GIC | News | $40.52 0.87% 0.0% 56K twitter stocktwits trandingview |
Retail Trade
| Email alert Add to watchlist

electronics trial
3D Systems Announces Expansion Plans to Address Rising Demand for New Healthcare and Industrial Applications
Published: 2021-05-04 (Crawled : 13:00) - globenewswire.com
DDD F | $3.55 2.31% 0.0% 1.5M twitter stocktwits trandingview |
Producer Manufacturing
| | O: -1.61% H: 0.0% C: -2.93%

expansion trial application
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K twitter stocktwits trandingview |
| | O: -0.65% H: 10.38% C: 8.4%
LLY | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 1.36% C: 0.36%

covid clinical trials antibody trial covid-19
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements– Agreements are a major step for ongoing clinical trials and future commercial drug supply
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
PSTV | $1.67 -1.27% -1.28% 25K twitter stocktwits trandingview |
Health Technology
| | O: 15.77% H: 17.61% C: -20.27%

ongoing clinical trials collaboration drug trial chmp
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
CMPI | $10.5 0.0% twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 0.0% C: -3.42%

potential trial
BioLineRx Announces Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
Published: 2021-05-04 (Crawled : 11:00) - ir.biolinerx.com
BLRX | $0.6564 2.55% 2.48% 190K twitter stocktwits trandingview |
Health Technology
| | O: 53.29% H: 29.65% C: -0.2%

bone positive results phase 3 trial topline
ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Moderate to Severe Endometriosis-Associated Pain
Published: 2021-05-04 (Crawled : 05:00) - obseva.com
OBSV | $0.1018 -15.52% -18.95% 8.2M twitter stocktwits trandingview |
Health Technology
| | O: -2.38% H: 4.88% C: 3.83%

phase 3 trial linzagolix enroll
Gainers vs Losers
69% 31%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K twitter stocktwits trandingview |
Manufacturing

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.